PCSK9 and coronary artery disorder: Therefore, we designed this protocol to systematically summarise the effects of PCSK9 inhibitors on coronary microcirculation and cardiac function in patients with CHD after PCI, and to provide high-quality evidence-based medical evidence for the clinical application of PCSK9 inhibitors.